
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
1066 | Hong Kong | HKD | Delayed | |
SHWGY | OTC Markets | USD | Delayed | |
8199 | Frankfurt | EUR | Delayed |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and orthopedic products comprise spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. Its pharma packaging products consist of prefilled drug delivery systems, pharmaceutical packaging consumables, automatic drug delivery systems, and pre-filled syringes; interventional products include offers tumor, vascular, and nursing interventions; and blood management products comprise whole blood collection consumables and blood transfusion equipment. The company also provides finance leasing and factoring services; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture instruments; computer technical services; consulting services; and X-ray based irradiation machines. In addition, it sells electronic products. The company was founded in 1988 and is based in Weihai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Qiang Li | 49 | 2022 | Independent Non-Executive Director |
Heng Sun | 60 | 2024 | Independent Non-Executive Director |
Dapeng Song | 48 | 2022 | Shareholders Representative Supervisor |
Rinan Cong | 44 | 2021 | CEO & Executive Director |
Zhuangqiu Zhang | 49 | 2022 | Employee Representative Supervisor |
Jing Long | 50 | 2013 | Executive Chairman of the Board & Compliance Officer |
Hong Meng | 59 | 2022 | Independent Non-Executive Director |
Zhengpeng Tang | 54 | 2021 | Non-Executive Director |
Lin Chen | 48 | 2021 | Non-Executive Director |
Meijun Gu | 47 | 2020 | Chairman of the Supervisors |
Guohui Li | 54 | 2022 | Independent Non-Executive Director |
Junqiang Lu | 51 | 2022 | Executive Director |
Daoming Wang | 45 | 2024 | Executive Director |
Xia Yan | 49 | 2024 | Vice-Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review